PPOS · 2026
What do we know about PPOS safety?
Separate neonatal findings, embryo chromosome evidence and longer-term unanswered questions.
Reassuring neonatal findings
The consensus states that current evidence does not show increased risks of birth defects or adverse neonatal outcomes with PPOS (recommendation 21, 1B). Studies comparing birthweight, prematurity and low birthweight generally found no statistically significant differences between the studied protocols.
Consensus recommendations: 21
Chromosomes are a separate question
Evidence about embryo aneuploidy is not conclusive. Several retrospective studies report comparable results, but findings vary across populations and study designs. The neonatal recommendation should not be read as proof that every chromosome-related question has been settled.
Consensus recommendations: 21
What still needs follow-up?
Long-term offspring health needs larger studies and longer follow-up, including neurodevelopmental and metabolic outcomes. During treatment, safety also depends on individualized monitoring and OHSS prevention. The evidence helps guide a discussion with the clinician; it does not guarantee a particular outcome.
Fertility Group